ARTICLE | Finance
With $30M from Medicxi, Aldena aims to bring siRNA to dermatology
Typically more focused on asset-centric investing, VC backs platform play with programs moving toward clinic next year
March 16, 2023 10:52 AM UTC
A $30 million funding from Medicxi, the largest seed investment in the firm’s history, positions newly launched Aldena to bring its first siRNA therapeutics for dermatological indications into the clinic.
The European firm hatched the idea of bringing together technologies from the University of Massachusetts Chan Medical School and Georgia Institute of Technology to allow non-systemic delivery of siRNA therapies against validated targets via a microneedle technology to the skin, Medicxi’s Francesco De Rubertis told BioCentury. Uniting the technologies, the firm founded Aldena Therapeutics Inc...
BCIQ Company Profiles